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Association between malaria control and
paediatric blood transfusions in rural Zambia:
an interrupted time-series analysis
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Sonali Korde4, Allen S Craig5,6, Nancy Nachbar1, Yann Derriennic1, Rose Gabert1,8 and Philip E Thuma7

Abstract
Background: Blood transfusions can reduce mortality among children with severe malarial anaemia, but there is
limited evidence quantifying the relationship between paediatric malaria and blood transfusions. This study
explores the extent to which the use of paediatric blood transfusions is affected by the number of paediatric
malaria visits and admissions. It assesses whether the scale-up of malaria control interventions in a facility catchment
area explains the use of paediatric blood transfusions.
Methods: The study was conducted at a referral hospital for 13 rural health centres in rural Zambia. Data were used
from facility and patient records covering all paediatric malaria admissions from 2000 to 2008. An interrupted time
series analysis using an autoregression-moving-average model was conducted to assess the relationship between
paediatric malaria outpatient visits and admissions and the use of paediatric blood transfusions. Further investigation
explored whether the use of paediatric blood transfusions over time was consistent with the roll out of malaria control
interventions in the hospital catchment area.
Results: For each additional paediatric malaria outpatient visit, there were 0.07 additional paediatric blood transfusions
(95% CI 0.01-0.13; p < 0.05). For each additional paediatric admission for severe malarial anaemia, there were 1.09
additional paediatric blood transfusions (95% CI 0.95-1.23; p < 0.01). There were 19.1 fewer paediatric blood
transfusions per month during the 2004–2006 malaria control period (95% CI 12.1-26.0; p < 0.01), a 50% reduction
compared to the preceding period when malaria control was relatively limited. During the 2007–2008 malaria control
period, there were 27.5 fewer paediatric blood transfusions per month (95% CI 14.6-40.3; p < 0.01), representing a 72%
decline compared to the period with limited malaria control.
Conclusions: Paediatric admissions for severe malarial anaemia largely explain total use of paediatric blood
transfusions. The reduction in paediatric blood transfusions is consistent with the timing of the malaria control
interventions. Malaria control seems to influence the use of paediatric blood transfusions by reducing the number of
paediatric admissions for severe malarial anaemia. Reduced use of blood transfusions could benefit other areas of the
health system through greater blood availability, particularly where supply is limited.
Keywords: Malaria control, Blood transfusion, Severe malarial anaemia, Paediatric hospital admissions, Zambia,
Sub-Saharan Africa, Time series
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Background
Malaria is one of the leading causes of child mortality
in sub-Saharan Africa (SSA). According to the most recent estimates from the World Health Organization
World Malaria Report 2013, malaria accounted for approximately 627,000 deaths world-wide in 2012, of
which almost 77% were among children under five
years of age [1]. Malaria has been recognized as a major
contributor to anaemia among children [2]. Severe malarial anaemia is a common presentation of severe malaria in children under five years of age [3], and is one
of the primary causes of hospitalization and death for
children in SSA [4]. Severe malarial anaemia was found
in 17% of all malaria admissions among children aged
zero to nine years in a study of 13 hospitals across
Africa [5]. A review of studies on malaria control interventions in SSA found that moderate-to-severe anaemia
in children is more than halved with the introduction of
interventions, including insecticide-treated nets and intermittent presumptive treatment [6]. Most severe forms of
malaria and most malaria-related deaths are caused by the
parasite Plasmodium falciparum [7].
Evidence demonstrates that blood transfusions can
save the lives of children with severe malarial anaemia
[8,9], and also shorten recovery time from anaemia [10].
Delays in the receipt of blood transfusions can significantly increase mortality among patients, particularly for
those with severe malarial anaemia, and improved availability of blood could prevent some of these deaths
[8,11-14]. Specifically in SSA, evidence shows that anaemia as a result of malaria accounts for up to 70% of all
paediatric blood transfusions [9]. Over 60% of deaths in
children with severe malarial anaemia occur before a
transfusion is given [15]. In Tanzania, malarial anaemia
accounted for 98% of all paediatric blood transfusions
among children receiving blood transfusions in the
paediatric wards of two hospitals [11]. In Kenya, 88% of
one hospital’s paediatric blood transfusions over the
course of a year were for children with severe anaemia
[12], likely associated with malaria.
Other frequent uses of blood transfusions, particularly
in low- and middle-income countries, include severe obstetrical haemorrhage, trauma, and severe childhood anaemia, which is often but not always due to malaria
[13,16]. Despite the widespread need for blood transfusions for anaemia and other conditions, it is well documented that maintaining an adequate safe blood supply
can be a significant challenge, particularly in SSA
[13,17,18]. Efforts to maintain adequate blood supplies
have become more challenging in recent years due to
increasingly stringent blood safety and quality assurance practices to address risks related to infectious diseases (such as HIV, hepatitis B and C, and syphilis) and a
related trend towards centralizing blood collection and
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management. Together, these factors can contribute to
delaying the receipt of potentially life-saving blood [19,20].
Given the extensive use of blood transfusions to treat
severe malarial anaemia, particularly among children, reducing the incidence of malaria through improved malaria control could substantially reduce the need for
paediatric blood transfusions. In turn, reductions in the
use of paediatric blood transfusions could benefit nonmalaria patients, such as trauma patients or patients
with post-partum haemorrhage, particularly in areas
with blood supply shortages. There is limited research
assessing the effect of malaria control on the use of
paediatric blood transfusions. Two studies focused on
the effects of improved malaria treatment. In Zanzibar,
the number of blood transfusions for children under five
years of age fell by 67% with the introduction of
artemisinin-based combination therapy (ACT) [21]. In
Zambia, uncomplicated malaria patients receiving the
combination therapy atovaquone-proguanil (AP) required
no blood transfusions, while 8% of patients receiving
sulphadoxine-pyrimethamine (SP) required a blood transfusion within 14 days of treatment initiation [22]. Only
one study, conducted in Ghana, has focused on malaria
control programmes more broadly; this study found that
the frequency of blood transfusions for patients with confirmed malaria decreased from 24.1% to 11.3% following
the implementation of Ghana’s malaria control program
in one of Ghana’s districts [9].
Using retrospective time-series data from 2000 to 2008
from one hospital in Zambia, this study quantifies the
extent to which the use of paediatric blood transfusions
is associated with the number of paediatric malaria outpatient visits, paediatric malaria admissions, and paediatric admissions for severe malarial anaemia. Paediatric
admissions for severe malarial anaemia are a subcategory of all paediatric malaria admissions; other malaria admissions include complications such as malarial
anaemia, cerebral malaria, and the combination of
these. This study tests the underlying assumption that a
reduction in malaria outpatient visits is associated with
a reduction in malaria admissions, which in turn may
influence blood transfusion use. The rate at which malaria outpatient visits decrease over time relative to inpatient malaria admissions may depend on factors such
as hospitals continuing to admit the most serious malaria cases. This study seeks to test these various relationships to better understand their associations with
each other and, ultimately, their relationship with
paediatric blood transfusion use.
The study then investigates whether the use of paediatric blood transfusions is associated with the scale-up
of malaria control efforts in the hospital’s catchment
area over time. Specifically, it assesses whether there is a
difference in the rate of monthly use of paediatric blood

Comfort et al. Malaria Journal 2014, 13:383
http://www.malariajournal.com/content/13/1/383

transfusions before and after malaria control scale-up, as
well as a difference in the average monthly use before
and after scale-up. Not only does this study complement
the evidence from Ghana on the effect of malaria control
scale-up on paediatric blood use, it also quantifies the
extent to which the use of paediatric blood transfusions
varies with paediatric malaria visits and admissions.
This study also explores the seasonality of paediatric
blood use, for which there is limited evidence. Countries
with high seasonality of malaria incidence are those
where 60% of the annual rainfall occurs within three
months; these countries mostly include SSA countries
located in the Sahel and sub-Sahel [23]. In Zambia, the
number of paediatric malaria admissions peak following
the peak in rainfall during the rainy season [24]. If paediatric blood use is seasonal, there may be implications for
blood availability for non-malaria patients, particularly
during the high malaria transmission months. The findings would not only substantiate the relationship between paediatric malaria visits and the use of paediatric
blood transfusions, but also suggest that there may be
potential benefits to non-malaria patients from reduced
paediatric blood transfusions, particularly during the
high malaria transmission season.
Finally, this study conducts exploratory analyses to identify whether total blood use at the hospital is influenced
by blood use in the paediatric ward. It also tests whether
use of blood transfusions in the paediatric ward affects
use of blood transfusions in other patient wards, to identify potential spillover effects (or indirect benefits) for
other patients. There are no known studies assessing the
potential benefits of malaria control scale-up for nonmalaria patients, by freeing up blood supply for other
conditions.

Methods
Study area

This study was conducted in Zambia, a country in
southern Africa with historically high prevalence of malaria that has made significant progress in reducing malaria morbidity and mortality over the past decade [25].
Zambia was an early adopter of effective malaria control
interventions, including ACT as a first-line treatment,
free rapid diagnostic tests (RDTs), mass distribution of
insecticide-treated nets (ITNs), and wide deployment of
targeted indoor residual spraying (IRS) [25]. The data
for this study were collected from Macha Mission Hospital (MMH), a 208-bed facility (including 55 paediatric
beds) located in rural Choma District in Southern Province. MMH serves as the referral hospital for 13 rural
health centres in parts of Choma, Namwala and Kalomo
Districts. The hospital has its own hospital-affiliated
health centre, serving as an outpatient department. MMH
has been involved in malaria research for over 20 years,
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and is currently the site for the Macha Research Trust, the
successor to the Malaria Institute at Macha (MIAM)
established in 2003. Macha was selected for this study
given its extensive record-keeping during the last decade
resulting in high-quality data on both malaria services and
blood transfusions specifically.
Malaria transmission in MMH’s catchment area, covering approximately 160,000 people, has traditionally
been hyperendemic transmission of Plasmodium falciparum [26]. Anopheles arabiensis are the main vector responsible for malaria transmission in the Macha area
[27]. A 2002 entomological study conducted in the
catchment area found that the entomological inoculation
rate (EIR) was estimated to be 81 infected bites per person per year (unpublished observations; Siachinji et al.
2003); this EIR is similar to other countries in subSaharan Africa and lower than many countries in West
Africa [28].
In Southern Province, there is one rainy season from
November to April, followed by a cool dry season
(April-August) and a hot dry season (August-November)
[24]. Data show that paediatric malaria admissions at
MMH closely follow the timing of the rainy season. During a severe drought in Southern Province from November 2004 to April 2005, malaria transmission was nearly
zero resulting in very low paediatric malaria admissions.
Normal rain returned during 2005–2006 rainy season,
and paediatric malaria admissions increased, though they
were lower than pre-drought admissions [24].
Timeline of malaria control scale-up in MMH catchment
area

In 2003, the Zambian government introduced a revised
malaria treatment policy by including ACT, specifically
artemether-lumefantrine (AL), making Zambia the first
country in Africa to adopt ACT as the national first-line
therapy for the treatment of uncomplicated malaria.
MMH introduced ACT as its first line of treatment soon
after the policy shift (Figure 1). Kalomo District, which
includes part of MMH’s catchment area, was among the
first seven districts in Zambia to receive ACT in early
2003 [29]; ACT then became available in Choma District
in late 2003 and in Namwala District in late 2004. In late
2003, as part of a larger epidemiologic study, a community malaria test-and-treat and education campaign was
carried out in a random sample of villages in the hospital catchment area. All consenting residents were
screened for malaria by RDT, and those that tested positive were treated with ACT whether they were symptomatic or asymptomatic.
In 2005, the three districts in MMH’s catchment area
received RDTs in line with the National Malaria Control
Programme’s new policy to strengthen malaria diagnosis
with RDTs [30]. In addition, ITN distribution was scaled
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Figure 1 Macha Mission Hospital malaria control interventions over time. Diagram depicting both national and local changes in malaria
control and blood transfusion policy.

up in Choma District from 2003 to 2005. In 2006, government purchasing challenges at the central level led
to ACT shortages throughout Zambia; however, ACT
stocks returned to adequate levels in 2007 (Thuma, unpublished data). In 2006, 1,000 ITNs were distributed
in one community in MMH’s catchment area, but there
was no widespread distribution of ITNs in other parts
of the catchment area before 2007 [24]. While the Malaria Indicator Survey data are not disaggregated at the
district level, province level data show that ITN ownership increased from 47% in 2006 to 70% in 2008 in
Southern Province, but use of ITNs increased only marginally (from 30% to 32% of children under five)
[31,32]. In 2007, MIAM participated in the Ministry of
Health’s ITN distribution campaign for the northern part
of Choma District, distributing 24,000 ITNs through eight
rural health centres surrounding the hospital; this effort
raised the self-reported rate of ITN use in the previous
night to over 80% in MMH’s catchment area [28]. Although targeted IRS was rolled out in Choma District in
2008, it was restricted to peri-urban areas, thereby not
reaching MMH’s catchment area.
Data sources

The study uses retrospective monthly time-series data,
drawn from facility and patient records from 2000 to
2008. Inpatient malaria admission data, available from
2003 to 2008, were extracted from an electronic database that included all malaria admissions for patients
five years and under. These data include patient age, sex,
length of stay, malaria microscopy results, primary and
secondary discharge diagnosis, treatment for malaria
(including blood transfusions), and co-morbidities. Data
on monthly under-five outpatient visits for malaria
were extracted from the hospital-affiliated health centre

disease aggregation forms and were available for the
period 2000–2008.
Monthly blood transfusion data for the paediatric (five
and under), maternity, women’s, men’s, and tuberculosis
wards were collected from an electronic database tracking all blood transfusions given at MMH from 2000
through 2008. The database was periodically consolidated by Macha Research Trust using the hospital-based
laboratory blood bank transfusion log books; the senior
author on this study coordinated and supervised the
quality of these data throughout the reference period of
the study to ensure quality and consistency. The data
represent total monthly blood transfusions given by
ward. Transfusions are measured as the number of
transfusions completed per patient, and not as a measure of the units of blood transfused. Blood transfusion
data specifically for paediatric malaria admissions were
obtained from an electronic database of all paediatric
malaria admissions from 2003–2008. The analyses used
the data on total paediatric blood transfusions rather
than paediatric blood transfusions for severe malarial anaemia from these patient records. These latter data were
only available for 2003–2008, limiting the number of
time points prior to malaria control scale-up. The statistical correlation between total paediatric blood transfusions and those used for severe malarial anaemia is high
(0.94), justifying the use of total paediatric blood transfusion as a proxy for those used for severe malarial
anaemia.
Given differing data sources and data management approaches among sources, the data on total hospital admissions and outpatient visits use different age thresholds
than the malaria admission and blood transfusion data.
The HMIS data report data for children under five
years of age, while the electronic database on paediatric
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inpatient malaria admissions and blood transfusion reports data on children five years and under. Although
there is a discrepancy in the age categorization across
sources, this does not affect the main analysis between
malaria admissions and paediatric blood transfusions
since the same age threshold is used. Hereafter, for simplicity, all patient data will be referred to as paediatric
cases.
For this study, paediatric admissions with severe malarial anaemia and cerebral malaria with severe anaemia were
classified based on the first and second discharge diagnosis in the patient records. Severe malarial anaemia was diagnosed if haemoglobin (Hb) <5 g/100 ml. At MMH, the
criteria for transfusion is haemoglobin less than or equal
to 5 g/100 ml, consistent with the WHO guidelines for
treating severe anaemia. In reality, blood transfusions may
have been given to patients with Hb >5 at the discretion
of the physician if the patient was thought to be unstable,
had very high parasitaemia, experienced cardiac failure, or
had co-existing malnutrition. Because the blood transfusion data for the paediatric malaria admissions were
drawn directly from patient records, these transfusions are
reflected in the data. Cerebral malaria with severe anaemia
was diagnosed if a child has a positive malaria smear with
coma (Blantrye Coma Score ≤2) with no other cause
found for the coma, and also had Hb <5 g/dl.
Analytical approach

The aim of this study was to assess the extent to which
the use of blood transfusions in the paediatric ward is
associated with the number of paediatric outpatient malaria visits, paediatric inpatient malaria admissions, and
paediatric inpatient admissions for severe malarial anaemia. It then explores whether this association can be
attributed to the scale-up of malaria control interventions in MMH’s catchment area, based on the timing of
these interventions. The following presents the hypothesized logic model relating malaria control scale-up with
use of paediatric blood transfusions: First, effective malaria control should reduce the incidence of malaria in
the hospital’s catchment area. A decrease in malaria incidence across the population should reduce the number of
paediatric outpatient malaria visits. More effective malaria
control, through prevention, should decrease the number
of malaria cases. In addition, more effective first-line treatment should decrease the number of severe malaria cases,
including severe malarial anaemia. Together, the number
of admissions for malaria should fall. Since a large portion
of paediatric blood transfusions are used for malaria, a reduction in these admissions should reduce the use of
paediatric blood transfusions overall.
Malaria control scale-up may also indirectly affect the
use of blood transfusions in other patient wards. If the
blood supply is limited at a health facility and there are
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competing uses for blood resources, a decline in blood
transfusion use in one ward may result in greater blood
availability for other wards. If blood transfusion use in
the paediatric ward declines with malaria control scaleup, then more blood may be available for use in other
wards. These potential spillover effects (or indirect benefits) are most likely to occur if the total blood supply is
fixed or limited, and if it is rationed between wards;
otherwise, such spillover effects may not exist, or may
be relatively small.
All analyses used an autoregressive-moving-average
(ARMA) model to account for potential autocorrelation
of time-series data. By accounting for the potential correlation over time in the outcome variable, this model prevents the observed effects from being confounded by
secular trends over time, which also affect the outcome.
The model also accounts for potential correlation of the
residual (unobserved) term over time. Based on the autocorrelation function for the monthly paediatric blood
transfusion data, the best-suited model for the main analyses included two lag variables for both the autoregressive
model and the moving-average model (defined as a AR(2)
MA(2) model which means that there exist correlations
across the two most recent time periods). The ARMA
model uses a maximum likelihood estimator. To account
for potential unequal variance in the error term by year
(heteroskedasticity), the model used robust standard errors. All analyses were conducted using Stata SE (version
11.0, StataCorp).
The main outcome of interest was the number of
monthly paediatric blood transfusions. The first analyses
quantified the relationship between the use of paediatric
blood transfusions and the number of paediatric malaria
outpatient visits. In this model, the regression included an
interaction term that identifies the 2004–2008 period
which represents the time period of malaria control scaleup in MMH’s catchment area. The interaction term shows
whether the relationship between paediatric malaria visits
and paediatric blood transfusions changes when malaria
control is scaled-up. Similar analyses were conducted
using paediatric malaria admissions and paediatric admissions for severe malarial anaemia, respectively, as the independent variables.
The next set of analyses used an interrupted time
series model to investigate whether the rate of use of
paediatric blood transfusions is different when malaria
control is scale-up and whether the average number of
paediatric blood transfusions used differs as well. In
these models, the independent variables included: 1) a
monthly trend variable for the 2000–2003 period, 2) a
variable capturing the average difference in quantity of
paediatric blood transfusions used per month during the
2004–2008 period relative to the 2000–2003 period, and
3) a monthly trend variable for the 2004–2008 period.
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The 2000–2003 monthly trend variable represents the
rate of paediatric blood transfusion use prior to malaria
control scale-up in the hospital’s catchment area. The
2004–2008 monthly trend variable identifies the rate of
paediatric blood transfusion use from 2004–2008, representing the malaria control scale-up period. A comparison of these two variables shows whether the rate of use
is different before and after malaria control scale-up.
The difference in monthly use variable identifies whether
average number of monthly paediatric blood transfusions used during the 2004–2008 period is different than
the monthly average used in the 2000–2003 period. A
similar model was run separating the malaria control
scale-up period into two periods: 2004–2006 and 2007–
2008. This specification allows the monthly trend
(change in use over time) and average difference in
monthly use during both post scale-up periods to be different from each other, since different malaria control
activities were taking place in these two periods. In
addition, 2006 was a year when malaria control was limited because of the ACT shortage. By separating these
years, this allows the magnitude of the effects to differ.
The model assumed that all years prior to 2004 were
considered years when malaria control was not scaled
up in MMH’s catchment area. The next set of analyses
used the same model but included, as the dependent
variable in separate regressions, the number of paediatric
malaria outpatient visits, paediatric malaria admissions,
and paediatric admissions for severe malarial anaemia,
respectively. These analyses served to confirm whether
the changes in the use of paediatric blood transfusions
as a function of malaria control scale-up could be explained by the changes in malaria outpatient visits and
malaria inpatient admissions related to malaria control
scale-up.
Exploratory analyses were conducted to identify the
relationship between paediatric blood transfusion use
and total use of blood transfusions at the hospital. Similar analyses were also done using, as dependent variables, blood transfusion use in different patient wards,
including the maternity, women’s, men’s, and tuberculosis ward. These analyses include an interaction term,
to assess whether the relationship between blood use in
the paediatric ward and blood use in other wards is different during the 2004–2008 malaria control scale-up
period.

Results
Trends over time in paediatric malaria admissions and
outpatient visits and blood transfusions at Macha Mission
Hospital

Summary statistics for both paediatric outpatient malaria
visits and paediatric malaria admissions at MMH show
substantial declines over time (Table 1). During the
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period 2003–2008, paediatric malaria admissions peaked
in 2003 (1,687 admissions) then followed a downward
trend, with 233 paediatric malaria admissions by 2008.
Despite the general decline in paediatric malaria admissions over this time period, there was an increase from
2005 to 2006 likely associated with the end of the 2004/
2005 drought and the ACT drug shortage. Similar downward trends over this time period occurred for paediatric
malaria outpatient visits, with an increase occurring in
2006 relative to 2005 despite a smaller relative number
of total outpatient paediatric visits. Outpatient paediatric
malaria visits then continued to decrease in 2007 and
2008. Malaria hospital admission data for Southern
Province show similar trends with a peak in malaria admissions in 2003, followed by a subsequent decline in
2004 and 2005. Malaria admissions increase in 2006,
relative to 2005, then continue to fall in 2007 and 2008.
The national trend over this time period is a consistently
downward trend, with admissions slightly higher in 2006
compared to 2005 [33].
Over the same period, yearly paediatric blood transfusions followed similar trends as paediatric malaria admissions and outpatient visits. In 2000, there were 588
blood transfusions in the paediatric ward (Table 2).
Yearly paediatric blood transfusions had fallen to 60 by
2005; they subsequently increased in 2006 to 225, and
then fell to 74 transfusions in 2008. Paediatric blood
transfusions for severe malarial anaemia are only available for the period 2003–2008. During this period, they
followed a similar trend as total paediatric blood transfusions, decreasing from 288 in 2003 to 40 by 2005, increasing to 121 in 2006 then falling to 21 in 2008.
Paediatric blood transfusions for severe malaria made up
73% of all paediatric blood transfusions in 2003.
Through 2007, the proportion of all paediatric blood
transfusions that were used for severe malarial anaemia
admissions is 67%, on average. In 2008, this proportion
fell to 28%. The yearly trend in total paediatric blood
transfusions and those used for paediatric admissions for
severe malaria anaemia follow a consistent trend over
time; paediatric admissions for severe malaria anaemia
follow exactly the same trend as the use of blood transfusions for these admissions (Figure 2).
The monthly trend for paediatric blood transfusions
followed a similar trend to the monthly trend in paediatric malaria admissions and paediatric outpatient malaria
visits (Figure 3). Figure 3 uses outpatient malaria visits
rather than inpatient malaria admissions because these
data were available over a longer time period. Outpatient
malaria visits can serve as a proxy for the malaria incidence although they represent an imperfect proxy because they do not capture malaria cases which were seen
at other lower level health centres or malaria cases that
were treated at home. Outpatient visits also serve as a
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Table 1 Total paediatric outpatient malaria visits and inpatient malaria admissions
Year

Outpatient malaria visits

Inpatient malaria admissions

Inpatient admissions for severe malarial anaemia

2000

6328

NA

NA

2001

5269

NA

NA

2002

4536

NA

NA

2003

5611

1687

282

2004

1660

579

89

2005

700

208

25

2006

1042

618

119

2007

969

471

74

2008

120

233

18

Note: Data for inpatient malaria admissions were only available for 2003-2008.

proxy for inpatient admissions since they are correlated.
As the number of paediatric outpatient malaria visits decreased, the monthly number of paediatric blood transfusions also dropped substantially. The monthly paediatric
blood transfusion trends also mirrored the seasonality of
malaria transmission in MMH’s catchment area.
The trend over time for the total number of blood
transfusions at MMH across all wards followed a similar
trend to paediatric blood transfusions (Figure 4). During
the period 2000 to 2008, the highest total number of
transfusions at MMH occurred in 2000, with 807 transfusions. Total transfusions fell to 305 in 2005, then increased to 544 in 2006 and subsequently fell to 335 in
2008. In 2000, the paediatric ward accounted for 73% of
total blood transfusions at MMH. The proportion fell to
20% in 2005 and 22% in 2008 (with an increase in 2006
to 41%). These data represent number of transfusions by
patient ward and not units of blood transfused, which
vary by patient weight. Similar trends exist for units of
blood transfused.

Association between paediatric malaria visits and
admissions and paediatric blood transfusions

The main results (Table 3) show that there is both a positive correlation between paediatric malaria visits and
paediatric blood transfusions as well as a positive correlation between paediatric malaria admissions (including
paediatric admissions for severe malarial anaemia) and
paediatric blood transfusions. In the first model (column
1), for each additional paediatric malaria outpatient visit,
there were 0.07 additional paediatric blood transfusions
(95% CI 0.01-0.13; p < 0.05), and for each additional paediatric admission for malaria, there were 0.19 additional
paediatric blood transfusions (column 3, 95% CI 0.03-0.35;
p < 0.05). Lastly, for each additional paediatric admission
for severe malarial anaemia, there were 1.09 additional
paediatric blood transfusions (column 5, 95% CI 0.95-1.23;
p < 0.01). Paediatric admissions for severe malarial anaemia are a subset of all paediatric malaria admissions.
This result suggests that a patient admitted for severe
malarial anaemia receives one blood transfusion, with

Table 2 Total pediatric blood transfusions over time (2000–2008)
Year Total
paediatric
blood
transfusions

Paediatric blood transfusions for
malaria admissions (percentage of total
paediatric blood transfusions)

Paediatric blood transfusions for severe
malarial anaemia admissions (percentage
of total paediatric blood transfusions)

Paediatric blood transfusions
(as percentage of all blood
transfusions at hospital)

2000 588

NA

NA

73%

2001 512

NA

NA

66%

2002 336

NA

NA

57%

2003 393

288 (73%)

288 (73%)

56%

2004 155

97 (63%)

89 (57%)

31%

2005 60

42 (70%)

40 (67%)

20%

2006 225

135 (60%)

121 (54%)

41%

2007 118

81 (69%)

77 (65%)

24%

2008 74

33 (45%)

21 (28%)

22%

Note: Data for inpatient malaria admissions were only available for 2003-2008.
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Figure 2 Pediatric admissions for severe malarial anaemia and paediatric blood transfusions at Macha Mission Hospital. Graphs shows
the yearly trends in paediatric admissions for severe malarial anaemia and paediatric blood transfusions.

some admitted patients receiving more than one blood
transfusion during their stay. It also demonstrates that
the paediatric admissions for severe malarial anaemia
largely explain total use of blood transfusions in the
paediatric ward. The interaction terms (identifying the
2004–2008 period) are not statistically significant for
paediatric malaria outpatient visits and paediatric malaria inpatient admissions (columns 2 and 4). This
means that the relationship between malaria cases (outpatient visits and admissions) relative to the use of
paediatric blood transfusions does not change over
time, as malaria control is scaled-up. However, the
interaction term is statistically significant for paediatric
admissions for severe malarial anaemia (column 6).
These results imply that, 2004–2008, there were 0.45
additional paediatric blood transfusions for every additional paediatric admission for severe malarial anaemia

(this estimate is the linear combination of the coefficient for paediatric severe malarial admissions (1.05)
and the coefficient for the interaction term (−0.60)).
Yet during the 2000–2003 period there were 1.05 additional paediatric blood transfusions for every additional
paediatric admission for severe malarial anaemia. These
findings indicate that, during the 2000–2003 period, if
there was one less paediatric admission for severe malarial anaemia, there was one less paediatric blood transfusion used, compared to a decrease of one half during
the 2004–2008 period.
Association between malaria control scale-up and
paediatric blood transfusions

The next analyses (Table 4) show that average rate of use
of paediatric blood transfusion during the 2000–2003
period is decreasing by 0.60 fewer blood transfusions per

Figure 3 Paediatric outpatient malaria visits and number of blood transfusions in the paediatric ward at Macha Mission Hospital.
Graph showing the similar monthly trends of paediatric blood transfusions, paediatric malaria admissions, and paediatric outpatient malaria visits.
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Figure 4 Total number of blood transfusions by ward at Macha Mission Hospital. Graph showing similar trends over time for the total
number of blood transfusions at Macha Mission Hospital across all wards. Note: the number of blood transfusions in the tuberculosis (TB) ward is
relatively small, which explains why they are not perceptible in the graph.

Table 3 Association between paediatric malaria outpatient visits, malaria admissions, malaria admissions for severe
malarial anaemia and paediatric blood transfusions
Dependent variable: paediatric blood transfusions
(1)
Paediatric malaria outpatient visits

(2)

0.07**

0.03**

(0.03)

(0.02)

Paediatric malaria outpatient visits X period 2004-2008

(3)

(4)

(5)

(6)

1.09***

1.05***

(0.07)

(0.06)

0.02
(0.03)

Paediatric malaria admissions

0.19**

0.21***

(0.08)

(0.02)
−0.08

Paediatric malaria admissions X period 2004-2008

(0.06)
Paediatric severe malarial anaemia admissions

−0.60***

Paediatric severe malarial anaemia admissions X period 2004-2008

(0.22)
Period 2004–2008 (dummy variable)

Constant

−16.59**

2.47

−0.46

(6.78)

(4.04)

(3.01)

11.17

27.51***

3.25

1.46

2.66*

4.66

(8.01)

(8.65)

(4.56)

(4.32)

(1.39)

(3.48)

Observations

102

102

72

72

72

72

Mean of dependent variable

23.77

23.77

14.24

14.24

14.24

14.24

Wald Chi-Squared

219.92

223.69

318.27

601.49

1.40e + 12

3483.32

*Significant at 10%; **significant at 5%; ***significant at 1%. Coefficient standard errors are noted in parentheses.
This table presents six different regressions where, in each regression, the dependent variable is the number of paediatric blood transfusions. Regressions use an
autoregressive-moving-average model with 2 lags and robust standard errors. We control for the month of the year in all regressions to account for seasonal
correlations. Period 2004–2008 variable is a dummy variable that takes on a value of 1 for the years 2004–2008, and 0 otherwise. The interaction term, Paediatric
malaria outpatient visits X period 2004–2008, is included to identify whether the association between paediatric malaria outpatient visits and paediatric blood
transfusions is different during the 2004–2008 period compared to the 2000–2003 period. The same definitions apply for the other interaction terms.
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Table 4 Association between malaria control scale-up over time and paediatric blood transfusions - interrupted time
series
Dependent variable: paediatric blood transfusions
Independent variables

(1)

(2)

Monthly trend 2000-2003

−0.60***

−0.52***

(0.12)

(0.10)

Difference in monthly use 2004–2008 (relative to 2000–2003)

−10.58***
(3.35)

Monthly trend 2004-2008

−0.02
(0.04)
−19.06***

Difference in monthly use 2004–2006 (relative to 2000–2003)

(3.56)
Monthly trend 2004-2006

0.34***
(0.10)
−27.47***

Difference in monthly use 2007–2008 (relative to 2000–2003)

(6.56)
−0.14

Monthly trend 2007-2008

(0.22)
Constant

56.59***

55.12***

(7.62)

(7.45)

Observations

108

108

Mean of dependent variable

22.79

22.79

Wald Chi-Squared

2734.85

3740.52

*Significant at 10%; **significant at 5%; ***significant at 1%. Coefficient standard errors are noted in parentheses.
Regressions use an autoregressive-moving-average model with 2 lags and robust standard errors. We control for the month of the year in all regressions to
account for seasonal correlations. For column 1, monthly trend 2000–2003 represents the rate of change by month for the outcome variable from 2000–2003.
Monthly trend 2004–2008 represents the rate of change by month for the outcome variable from 2004–2008. Difference in monthly use in 2004–2008 represents
the average difference in the outcome between 2000–2003 period and 2004–2008 period. For column 2, monthly trend 2000–2003 is defined as in column 1.
Monthly trend 2004–2006 represents the rate of change by month for the outcome from 2004–2006. Monthly trend 2007–2008 represents the rate of change from
2007–2008. Difference in monthly use in 2004–2006 represents the average difference in outcome between 2000–2003 and 2004–2006. Difference in monthly use
in 2007–2008 represents the average difference in outcome between 2007–2008 and 2000–2003.

month (column 1, 95% CI .058-0.62; p < 0.01). During
the 2004–2008 period, the rate of use remained constant over time since the variable representing the
monthly trend for the 2004–2008 period is not statistically significant. However, the difference in monthly
use during the 2004–2008 period is statistically significant. During the 2004–2008 period, there were, on
average, 10.6 fewer paediatric blood transfusions per
month compared to the 2000–2003 period (95% CI
4.01-17.15; p < 0.01). From an average of 38 paediatric
blood transfusions during the 2000–2003 period, this
represents a 28% reduction. In the second specification,
the malaria control scale-up periods are separated to
identify differences in effects during the 2004–2006 and
2007–2008 periods. During the 2000–2003 period, the
rate of paediatric blood transfusion use decreased by
0.52 per month (column 2, 95% CI 0.32-0.72; p < 0.01).
Average monthly use of paediatric blood transfusions
during the 2004–2006 fell by 19.06, representing a 50%

reduction in monthly paediatric blood use compared to
2000–2003 period. However, the rate of paediatric
blood use during this period increased by 0.34 per
month (column 2, 95% CI 0.14-0.54; p < 0.01). During
the 2007–2008 period, average monthly use of paediatric blood transfusions fell by 27.5 (column 2, 95% CI
14.6-40.3; p < 0.01), representing a 72% reduction compared to the 2000–2003 period. The rate of blood use
during the period 2007–2008 remains constant. The results in all analyses are not explained by seasonal differences in blood transfusions, because the analyses
control for average monthly differences in paediatric
blood transfusions, driven by factors such as malaria
transmission related to rainfall.
There is evidence of seasonal effects on use of paediatric
blood transfusions (Table 5). Over the study time period,
on average, monthly blood transfusions were significantly
lower in August through December, compared to January.
Peak use occurs in April at the end of the rainy season.
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Table 5 Association between malaria control scale-up over time and paediatric blood transfusions - interrupted time series
Dependent variable: paediatric blood transfusions
Monthly trend 2000-2003

Difference in monthly use 2004–2008 (relative to 2000–2003)

(1)

(2)

−0.60***

−0.52***

(0.12)

(0.10)

−10.58***
(3.35)

Monthly trend 2004-2008

−0.02
(0.04)
−19.06***

Difference in monthly use 2004–2006 (relative to 2000–2003)

(3.56)
Monthly trend 2004-2006

0.34***
(0.10)
−27.47***

Difference in monthly use 2007–2008 (relative to 2000–2003)

(6.56)
−0.14

Monthly trend 2007-2008

(0.22)
February

5.79
(4.53)

(4.70)

March

15.00

13.96

(9.64)

(9.86)

April

26.99*

26.43*

(14.34)

(13.81)

May

18.69

18.87

June

July

August

September

October

November

4.88

(13.41)

(12.64)

−9.22

−8.40

(11.51)

(11.79)

−16.37

−15.30

(10.70)

(11.78)

−20.81**

−20.01*

(10.22)

(11.76)

−23.94**

−23.87**

(9.84)

(11.26)

−24.08***

−24.90**

(8.96)

(9.95)

−24.54***

−26.06***

(7.47)

(8.03)

December

−9.89**

−11.60**

(4.70)

(5.56)

Constant

56.59***

55.12***

(7.62)

(7.45)

Observations

108

108

Mean of dependent variable

22.79

22.79

Wald Chi-Squared

2734.85

3740.52

*Significant at 10%; **significant at 5%; ***significant at 1%. Coefficient standard errors are noted in parentheses.
Regressions use an autoregressive-moving-average model with 2 lags and robust standard errors. The variables are identified as in Table 3. The month variables
represent a dummy variable for each month. The base (omitted) variable is January.
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Kent et al. find that this lag occurs because the highest
proportion of mosquitoes is actively transmitting at the
end of the rainy season [24].
Association between malaria control scale-up and
paediatric malaria visits and admissions

The next results (Table 6) show that the rate of paediatric outpatient malaria visits was decreasing at a rate of
0.96 fewer outpatient malaria visits per month during
the 2000–2003 period (column 1, 95% CI 0.29-1.63; p <
0.01). During the 2004–2008 period, the rate of paediatric outpatient malaria visits decreased at a higher rate,
with 1.41 fewer malaria outpatient visits per month (95%
CI 1.17-1.65; p < 0.01). There were also, on average, 309.4
fewer paediatric outpatient malaria visits per month during the 2004–2008 period, representing a 68% decrease
compared to the 2000–2003 period. The same analyses,
looking instead at paediatric malaria admissions, could
not be conducted because there is only one year of premalaria control data, insufficient to conduct an interrupted time series analysis.
The results also show that the relationship between
paediatric outpatient malaria visits and inpatient malaria
admissions does not change over time as malaria control
is scaled-up. The analysis (Table 7) shows that, for every
additional paediatric outpatient malaria visit, there were

0.3 additional paediatric malaria admissions (95% CI
0.22-0.38; p < 0.01). The second regression includes a
control variable for the 2004–2008 period and an interaction term to identify whether this relationship changes
with during this period, relative to 2000–2003 period.
This relationship does not change during the 2004–2008
period as the interaction term is not statistically significant. The relationship does change though for paediatric
admissions for severe malarial anaemia (column 4) since
the interaction term is statistically significant. During the
2000–2003 period, for every additional paediatric malaria
outpatient visit, there were 0.05 additional paediatric
admissions for severe malarial anaemia (95% CI 0.03-0.07;
p < 0.01). During the 2004–2008 period, there were 0.11
additional pediatric admissions for severe malarial anaemia; this result is the linear combination of the coefficient for outpatient malaria visits (0.05) plus the
coefficient with the interaction term (0.06). This results
means that the number of severe malarial admissions did
not fall at the same rate as the number of outpatient malaria visits, even though both of these fell substantially during the post-malaria control scale-up period. During the
post-malaria control scale-up period, the proportion of admissions for severe malarial anaemia relative to outpatient
malaria visits is 11% compared to 5% during the premalaria control scale-up period.
Association between paediatric blood transfusions and
blood transfusions in other wards

Table 6 Association between malaria control scale-up and
paediatric malaria visits, malaria admissions, and severe
malarial admissions - interrupted time series
Paediatric malaria
outpatient visits
Monthly trend 2000-2003

−0.96***
(0.34)

Difference in monthly use 2004–2008
(relative to 2000–2003)

−309.38***
(9.53)

Monthly trend 2004-2008

−1.41***

Constant

527.55***

Observations

102

(0.12)

(35.68)

Mean of dependent variable

258.05

Wald Chi-Squared

9.42e + 09

*Significant at 10%; **significant at 5%; ***significant at 1%. Coefficient
standard errors are noted in parentheses.
Regressions use an autoregressive-moving-average model with 2 lags and
robust standard errors. The monthly trend 2000–2003 represents the rate of
change by month for the outcome variable from 2000–2003. Monthly trend
2004–2008 represents the rate of change by month for the outcome variable
from 2004–2008. Difference in monthly use in 2004–2008 represents the
average difference in the outcome between 2000–2003 period and
2004–2008 period.

As part of the exploratory analyses, the last results
(Table 8) show that for every additional paediatric blood
transfusion, total blood transfusions used at the hospital
increased by 1.05 (column 1, 95% CI 0.95-1.15; p < 0.01).
For all regressions, a second regression is run which includes a control variable for the 2004–2008 period and
an interaction term to identify whether this relationship
changes with during this period, relative to 2000–2003
period. For total blood transfusions, the relationship
does not change during the 2004–2008 period compared
to the 2000–2003. These findings show that there is a
one-to-one relationship between the use of paediatric
blood transfusions and the overall use of blood transfusions at MMH. The relationships between paediatric
blood transfusions and the use of blood transfusions in
other patient wards are not statistically significant.

Discussion
Summary of main findings

In this study, the results show that the number of paediatric admissions for severe malarial anaemia largely explain
the number of paediatric blood transfusions used. This
finding highlights that reducing paediatric admissions for
severe malarial anaemia lowers the use of paediatric blood
transfusions. The results show a one-to-one relationship
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Table 7 Association between paediatric outpatient malaria visits and paediatric malaria admissions

Paediatric outpatient malaria visits

Dependent variable: paediatric
malaria admissions

Dependent variable: paediatric admissions for
severe malarial anaemia

(1)

(3)

(2)

0.30***

0.31***

0.05***

0.05***

(0.04)

(0.06)

(0.01)

(0.01)

Paediatric outpatient malaria visits X period 2004-2008

Period 2004–2008 (dummy variable)

Constant

(4)

0.13

0.06**

(0.11)

(0.03)

−11.80

−3.10

(27.09)

(7.81)

5.77

9.28

2.43

2.14

(8.29)

(24.67)

(3.06)

(8.29)

Observations

66

66

66

66

Mean of dependent variable

56.00

56.00

9.14

9.14

Wald Chi-Squared

1.31e + 11

1.38e + 12

161.61

594.00

*Significant at 10%; **significant at 5%; ***significant at 1%. Coefficient standard errors are noted in parentheses.
Regressions use an autoregressive-moving-average model with 2 lags and robust standard errors. We control for the month of the year in all regressions to
account for seasonal correlations. Period 2004–2008 variable is a dummy variable that takes on a value of 1 for the years 2004–2008, and 0 otherwise.

2008 period 86% of these admissions received a blood
transfusions compared to 96% during the 2000–2003
period. One possible explanation is that blood transfusions
for severe malarial anaemia start to make up a smaller
share of all paediatric blood transfusions (28% by 2008).
Some of the paediatric blood transfusions are being used
for other malaria admissions, specifically malarial anaemia admissions suggesting that a higher threshold
may have been used for transfusing. Some paediatric

between paediatric admissions for severe malarial anaemia
and paediatric blood transfusion use during the 2000–
2003 period. This relationship appears to be affected by
malaria control scale-up. As paediatric admissions for severe malarial anaemia decrease during the 2004–2008
period, paediatric blood transfusions continue to decrease
but at a slower rate. This result is not due to an increase
in use of blood transfusions among these admissions during the 2004–2008 period. Actually, during the 2004–

Table 8 Association between paediatric blood transfusions and blood transfusions in other wards

Paediatric blood transfusions

Dependent
variable: total
blood
transfusions

Dependent variable: Dependent
blood transfusions in variable: blood
transfusions in
maternity ward
men's ward

Dependent
variable: blood
transfusions in
women's ward

Dependent variable:
blood transfusions in
TB ward

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

(9)

(10)

1.05***

1.06***

−0.00

0.00

0.02

0.03

0.01

0.04

0.00

0.00**

(0.05)

(0.04)

(0.01)

(0.01)

(0.02)

(0.02)

(0.02)

(0.02)

(0.00)

(0.00)

Paediatric blood transfusions X period
2004-2008

Period 2004–2008 (dummy variable)

Constant

Observations

0.04

0.00

−0.00

0.03

−0.00

(0.10)

(0.03)

(0.08)

(0.07)

(0.00)

4.47

0.45

2.98*

1.98

0.18**

(3.28)

(0.74)

(1.78)

(1.89)

(0.09)

21.54*** 18.61*** 5.04***

4.65***

5.42***

3.46**

12.11***

10.25***

0.06

−0.05

(2.43)

(2.92)

(1.16)

(1.21)

(1.32)

(1.63)

(1.17)

(1.78)

(0.11)

(0.11)

108

108

108

108

108

108

108

108

108

108
0.11

Mean of dependent variable

46.85

46.85

3.60

3.60

6.55

6.55

13.81

13.81

0.11

Wald Chi-Squared

2145.86

2427.16

2.33e + 12

1.22e + 13

314.94

238.78

12907.44

14233.20

8.56e + 10 1.05e + 07

*Significant at 10%; **significant at 5%; ***significant at 1%. Coefficient standard errors are noted in parentheses.
Regressions use an autoregressive-moving-average model with 2 lags and robust standard errors. We control for the month of the year in all regressions to
account for seasonal correlations. Period 2004–2008 variable is a dummy variable that takes on a value of 1 for the years 2004–2008, and 0 otherwise.
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blood transfusions are also for non-malaria patients
(55%). The use of paediatric blood transfusions for
non-malaria patients follows a similar pattern to the
use by malaria patients. The trend in paediatric blood
transfusions for non-malaria admissions also follows a
similar pattern over time consistent with malaria control scale-up. One probable explanation is that these
non-malaria patients may have been treated successfully for malaria at another facility, but were referred to
MMH because of severe anaemia as a result of the recent malaria infection. Such patients would have received a blood transfusion if their haemoglobin was less
than 5 but the discharge diagnosis would not identify
them as malaria patients.
The results show that fewer blood transfusions were administered on the paediatric ward in years when malaria
control was scaled up in MMH’s catchment area compared to years when malaria control was not scaled up.
Compared to the 2000–2003 period when malaria control
was relatively limited, there was a 50% reduction in the
average monthly use of paediatric blood transfusions from
2004–2006. During this period, ACT was introduced as
the first line of treatment and the test-and-treat campaign
was implemented (2004 and 2005). Although the monthly
number of paediatric blood transfusions is lower in this
period compared to 2000–2003, the rate of use was increasing during this period. One of the reasons for the increase in the rate of paediatric blood transfusions during
this period is likely due to the countrywide ACT shortage
in 2006. This ACT shortage may have led patients to either bypass the health centre or receive hospital referrals
because of treatment shortages at the lower levels of
care [28]. In addition, the shortages caused recourse to
less effective treatment, primarily SP, to which resistance was prevalent, potentially leading to ineffective
treatment that resulted in progression of malaria and
subsequent hospitalization [34].
During the period 2007–2008, there was a 72% reduction in the monthly use of paediatric blood transfusions
compared to 2000–2003. The ITN distribution campaign
was rolled out during this period. The results comparing
the 2004–2008 period with the 2000–2003 period are
consistent with these findings, but the magnitude of the
relationship with paediatric blood transfusions is smaller.
This is again likely due to the increase in malaria visits
and admissions in 2006 associated with the ACT shortage, which may have dampened the overall relationship.
While there may have been some malaria control occurring in 2006 (through ITN distribution), the scale was
not equivalent to the widespread distribution of ITNs
beginning in 2007. For these reasons, the results for the
two separate time periods are used to allow for the effect
from these different years to differ. The decrease in the
rate of paediatric blood transfusion use during the
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2000–2003 suggests that there may have been limited
malaria control during this period although much less
pronounced than during the scale-up period from 2004
onwards.
The substantial decline in paediatric outpatient malaria
visits during the 2004–2008 period is consistent with the
scale-up of malaria control interventions. This time period
is associated with a 68% decrease in paediatric outpatient
malaria visits. Although there are no available data on
malaria incidence in the hospital’s catchment area, data on
outpatient visits were used as a close proxy for malaria incidence. Certain limitations exist in interpreting these data
relative to malaria incidence: They do not represent confirmed cases of malaria until RDTs were introduced, and
they only include visits to MMH’s outpatient department
and not visits to other lower level health centres. Nonetheless, the consistent association between the timing of
malaria control scale-up and the decrease in paediatric
outpatient malaria visits substantiates the hypothesized
pathway through which malaria control scale-up could
affect paediatric blood transfusion use. In addition, the
analyses show a consistent correlation over time between
malaria outpatient visits and malaria inpatient admissions.
There is evidence that the rate at which paediatric outpatient malaria visits decreased is greater than the rate of
decrease in paediatric malaria admissions. With effective
malaria control, the number of outpatient malaria visits
may fall faster than admissions because the proportion of
cases that present at the health facility are in greater need
of admission. Another possible explanation is related to
the introduction of RDTs in 2007 at MMH, since prior
diagnosis based on clinical presentation has been shown
to over-estimate the number of malaria cases [24]. The
relative difference is small since both malaria outpatient
visits and malaria admissions for severe malarial anaemia
fall substantially over this time period.
There is also evidence of the seasonal use of paediatric
blood transfusions, consistent with the timing of the rainy
season. Fewer paediatric blood transfusions are used during dry season months relative to rainy season months,
which is consistent with the low and high malaria transmission months. Overall, these findings suggest that the
use of paediatric blood transfusions is driven both by differences in malaria transmission resulting from seasonal
variation (including severe drought), and by differences in
malaria incidence over time resulting from the scale-up of
malaria control efforts.
In the context of this particular hospital, there are no
identified spillover effects (or indirect benefits) from
the use of paediatric blood transfusions on the use of
blood transfusions in other patient wards. The evidence
demonstrates that there is a one-to-one relationship between paediatric blood transfusions and total use of
blood transfusions at MMH. This positive correlation
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suggests that there is not a fixed supply of blood at
MMH and/or that the need for blood does not exceed
the available supply at this particular facility. Blood
does not appear to be rationed between patient wards;
this explains why there are no indirect benefits on
blood use in other patient wards despite the substantial
differences over time in blood use in the paediatric
ward. However, it is not possible to completely rule out
that there could have been some rationing if paediatric
patients were prioritized. The data represent blood
transfusions used and not blood transfusions ordered,
so it is not feasible to measure the demand or need for
blood transfusions during this period. Another reason
that there may be no effect is due to the measurement
of blood transfusions; these are measured relative to
patients and adult patients will require a greater quantity of blood per transfusion relative to paediatric patients. As a result, a large effect on paediatric blood use
will translate to a smaller effect for adult patients.
Limitations

The analytical methods in this study are used to demonstrate correlations between the variables of interest, but
do not show whether the relationship is causal. One of
the main limitations of the study was the absence of district level malaria control coverage data in the study
area, preventing quantification of the relationship between particular malaria control interventions (ACT
availability and ITN distribution) and the use of paediatric blood transfusions. Another limitation is the absence
of malaria incidence data for the specific catchment area,
which would strengthen the identification of the relationship between malaria control scale-up and the use of
paediatric blood transfusions. Follow-up research with
more detailed information about malaria control coverage and malaria incidence could more precisely quantify
the relationship between malaria control scale-up and
blood transfusion use.
There are certain potential confounders in the analysis
that could not be controlled for. For example, there may
have been changes over time in provider admitting and
transfusing behavior or changes in the general quality of
care at the hospital. However, changes in these factors
would need to be contemporaneous with the malaria
control efforts to confound the results. In general, it is
unlikely that changes in provider transfusing behavior
explain these results because the guidelines for transfusions did not change over this time period at MMH and
were consistent with WHO requirements. Nonetheless,
there may have been variations by physician in terms of
blood transfusion decision-making. The threshold for
transfusing a paediatric patient is haemoglobin below 5;
however, a higher threshold may have been used by
some physicians and this would explain why more
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admissions for malarial anaemia received blood transfusions during the 2004–2008 period. There may also have
been changes in care-seeking behavior on the patient
side with increased awareness about malaria as malaria
control was scaled-up. There is no available evidence to
assess this potential confounder in this context.
The main results are not confounded by seasonal variation in rainfall since the analysis includes control variables for each month. In addition, the ARMA model
controls for trends over time in the outcome variable
which means that it accounts for average differences
such as weather patterns. However, the results may be
confounded by the drought that occurred during the
2005 rainy season. Given that this drought coincided
with the introduction of ACT in that year, it is not possible to distinguish, for that particular year, between the
differential effect of the malaria control interventions
relative to the seasonal effects from low rainfall. Nonetheless, both factors would affect malaria admissions in
a similar direction.
Another potential confounder relates to the changes in
blood collection processes at MMH during the study
period. Until 2006, MMH managed its own blood collection through blood drives. Starting in 2006, Ministry of
Health policy change disallowed local blood collection
throughout Zambia, requiring MMH to obtain blood
centrally. Anecdotal evidence indicates that this shift did
affect blood availability and use and may have resulted
in increased blood rationing within the facility. By collecting its own blood collection process prior to 2006,
MMH could potentially better manage changes in the
blood supply with more immediacy (such as requesting
immediate replacement blood donations from family
members). A large portion of the data for this study
come from the period before the policy change, which
suggests that the hospital could better manage blood
supply needs across wards when it had its own blood
banking. This would also explain the absence of any
spillover effects on other patient wards. The lower number of paediatric blood transfusions post-2006 cannot be
explained solely by blood supply constraints given that
the proportion of blood transfusions used in the paediatric ward relative to other wards also fell, from 73% in
2000 to 22% in 2008.
The results of this study are specific to MMH, which
may serve a different patient population than a semiurban or urban hospital or a lower-tiered facility. MMH
is also located in an area where malaria has typically
been hyperendemic, so the seasonal effects on paediatric
blood transfusions may be different than in areas where
malaria is holoendemic, mesoendemic or hypoendemic.
Finally, the results reflect the relationship between the
particular malaria control interventions that were implemented in MMH’s catchment area. The magnitude of
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the effect of malaria control interventions will depend
on the type of intervention and its effectiveness. Nonetheless, the trend in malaria admissions at MMH are
similar to the trends in malaria admissions in Southern
Province.

Conclusions
The efficacy of blood transfusions to save the lives of children with severe malarial anaemia is well understood, and
data from several studies show that the majority of paediatric blood transfusions in malaria-endemic countries in
SSA are given for this reason. This study provides important insights into the relationship between paediatric malaria visits and admissions and blood transfusion use and
how differences in paediatric blood transfusion use are related to the scale-up of malaria control interventions over
time.
This study demonstrates the extent to which paediatric
blood use is lowered as paediatric outpatient malaria visits
and paediatric admissions for severe malarial anaemia decrease. It also demonstrates that the significant reduction
in paediatric blood transfusion use over time is consistent
with the scale-up of malaria control interventions. These
interventions appear to decrease the number of malaria
visits, an imperfect proxy for malaria incidence. This study
is the first to investigate potential spillover effects, or indirect benefits, from reduced blood transfusion use in the
paediatric ward on blood use in other patient wards. The
results show that, in this particular facility, the blood supply does not appear to be fixed and there does not appear
to be substantial effects from differences in blood use in
the pediatric ward on blood use in other patient wards.
The study paves the way for follow-up research in other
facility settings to investigate the potential benefits on
health outcomes for non-malaria patients at the facility
level, particularly in the context of fixed or limited
blood supply. Such studies are particularly relevant in
the current context of critical blood supply shortages in
many developing countries, where blood supply may
not meet clinical demand both for malaria and nonmalaria patients.
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